NASDAQ
Ampio Pharmaceuticals, Inc. (AMPE) has a free cash flow growth of -316.04% as of Friday, May 29, 2026. This represents a 1248.03% decrease compared to its 12-month average of 27.53%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.